Recently, focusing on innovation in intravascular imaging,GentuityThe company announced withGEHealthcare(Nasdaq stock code:GEHC) Sign a strategic cooperation agreement,The two parties will engage in deep collaboration in the commercialization, technical integration, and market expansion of interventional cardiology imaging solutions.This collaboration is seen as a significant development in the field of cardiovascular intervention."Precision"+Key implementation cases of the "intelligentization" trend.

The collaboration aims to accelerate high-frequency Optical Coherence Tomography (OCT) and other advanced imaging technologies in clinical applications, optimizing product functionality and accessibility to help doctors diagnose and treat cardiovascular diseases more accurately. According to the agreement, both parties will jointly carry out marketing activities and explore the seamless integration of technical systems. In addition,GEHealthcarePlans to leverage its nationwide distribution network across the U.S. to expandGentuityThe market coverage of the product benefits more medical institutions.

GentuityThe core products include:

• High FrequencyOCTMobile Imaging System: Equipped with machine learning algorithms, it enables rapid device deployment and high-definition vascular imaging, significantly reducing procedure preparation time;

• Vis-Rx primeMicro-imaging Catheter: Dubbed by the industry as the "World's Smallest Imaging Catheter" (Diameter1.8Francs), can be used in percutaneous coronary intervention (PCI) Provides dynamic imaging of the entire vascular segment before and after surgery, assisting doctors in accurately assessing lesion characteristics.

President of the CompanyDesmond AdlerSaid: "Our technology, through AI optimization and user-friendly design, reduces operational complexity while improving surgical success rates. This collaboration with...GEHealthcareThe collaboration will drive these innovative achievements to reach a wider range of medical scenarios.”

GEHealthcareCEO of Cardiovascular and Interventional SolutionsJyoti GeraStated: "The company is always committed to the collaborative innovation of diagnostic, therapeutic, and monitoring technologies to tell the 'healthy story of the heart.' In cooperation with...Gentuity"The cooperation not only aligns with this mission but also reflects the shared commitment of both parties to improving healthcare quality and enhancing patient outcomes."

This collaboration marks a significant milestone in the field of cardiovascular interventions."Precision"+The Deepening of the "Intelligentization" Trend.GentuityMiniaturized imaging tools andGEHealthcareThe global channel resources are complementary, which is expected to shorten the cycle of advanced technology from research and development to clinical implementation.AdlerFurther pointed out: "The medical industry can truly create the greatest value for both doctors and patients only when complementary technologies are scaled up through strategic collaboration."

Currently,The two parties have launched a joint working group to accelerate technical alignment and market trials, with expectations for the future.12The specific product integration plan and distribution strategy will be announced within the month.This collaboration is expected to provide more efficient and affordable solutions for cardiovascular disease management; stay tuned for further developments.